ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,898.00
0.35%
S&P 500
5,354.90
0.15%
Dow Jones
38,764.74
-0.09%
US Dollar vs Yen
156.9595
0.08%
Brent Oil
81.315
2.48%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. MediWound Limited (MDWD)

  7. MediWound Limited (MDWD) ニュース

MDWD

MediWound (MDWD)

MediWound Limited
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MDWD
日付受信時刻ニュースソース見出しコード企業名
2024/05/3005 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2024/05/2920 : 28IH Market NewsUS Index Futures Drop Amid Rising Treasury Yields and Inflation Concerns, Oil Prices IncreaseNASDAQ:MDWDMediWound Limited
2024/05/2920 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2024/02/1510 : 43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MDWDMediWound Limited
2024/02/1221 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2024/01/0921 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2024/01/0821 : 05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MDWDMediWound Limited
2024/01/0821 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2024/01/0820 : 35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MDWDMediWound Limited
2023/12/2821 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/12/1606 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/11/2121 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/11/2121 : 03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/11/1321 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/09/2705 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/09/2119 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/08/1605 : 14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MDWDMediWound Limited
2023/08/1605 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/08/1605 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/08/0221 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/07/1805 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/07/1020 : 35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/07/0320 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDWDMediWound Limited
2023/06/0105 : 11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDWDMediWound Limited
2023/05/3020 : 05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDWDMediWound Limited
2023/05/0920 : 35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDWDMediWound Limited
2023/04/2105 : 08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDWDMediWound Limited
2023/04/0705 : 07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MDWDMediWound Limited
2023/03/1620 : 15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDWDMediWound Limited
2023/03/1620 : 11Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:MDWDMediWound Limited
 Showing the most relevant articles for your search:NASDAQ:MDWD

最近閲覧した銘柄

NYSE
BAC
Bank of America
NASDAQ
GOOGL
Alphabet
CCOM
US500
US 500
COIN
SOLUSD
Solana
AMEX
SPY
SPDR S&P 500
AMEX
XLF
Financial Select Sector
USI
USTECH100
US Tech 100
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
FX
USDEUR
US Dollar vs Euro
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有